Smith & Nephew (SNN) Profit After Tax (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Profit After Tax of $214.0 million for Q4 2024, up 24.42% year-on-year from $172.0 million in Q1 2024, and up 24.42% on a QoQ basis from $172.0 million in Q4 2023.
Smith & Nephew (SNN) Profit After Tax (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Profit After Tax for 16 consecutive years, with $214.0 million the latest figure, recorded in Q4 2024.
- Quarterly Profit After Tax rose 24.42% year-over-year to $214.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $768.0 million (up 17.43% YoY) and the FY2025 annual result came in at $625.0 million, up 51.7% from the prior year.
- Profit After Tax advanced to $214.0 million in Q4 2024 per SNN's latest filing, from $172.0 million in the prior quarter.
- Over the last five years, Profit After Tax for SNN reached as high as $214.0 million in Q4 2024 and fell as low as $100.0 million in Q4 2020.
- A 5-year average of $173.6 million and a median of $177.0 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2020 — Profit After Tax tumbled 67.64% — and 2021, when it surged 105.0%.
- Year by year, Profit After Tax stood at $100.0 million in 2020, then jumped by 105.0% to $205.0 million in 2021, then decreased by 13.66% to $177.0 million in 2022, then fell by 2.82% to $172.0 million in 2023, then advanced by 24.42% to $214.0 million in 2024.
- According to Business Quant data, Profit After Tax over the past three periods registered $214.0 million, $172.0 million, and $177.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 223.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 214.00 Mn |
| Dec 31, 2023 | 172.00 Mn |
| Dec 31, 2022 | 177.00 Mn |
| Dec 31, 2021 | 205.00 Mn |
| Dec 31, 2020 | 100.00 Mn |
| Dec 31, 2019 | 309.00 Mn |
| Dec 31, 2018 | 274.00 Mn |
| Dec 31, 2017 | 324.00 Mn |
| Dec 31, 2016 | 241.00 Mn |
| Dec 31, 2015 | 295.00 Mn |
| Dec 31, 2014 | 239.00 Mn |
| Sep 30, 2014 | 102.00 Mn |
| Mar 31, 2014 | 160.00 Mn |
| Dec 31, 2013 | 693.00 Mn |
| Mar 31, 2013 | 162.00 Mn |
| Dec 31, 2012 | 140.00 Mn |
| Jun 30, 2012 | 309.00 Mn |
| Mar 31, 2012 | 140.00 Mn |
| Dec 31, 2011 | 215.00 Mn |
| Sep 30, 2011 | 442.00 Mn |